Cary Street Partners’s AB InBev BUD Stock Holding History

Cary Street Partners’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.3K	Buy	+805	New	+$63.3K	﹤0.01%	1028

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Cary Street Partners's BUD Position: Q2 2026 in Review

Cary Street Partners opened a new position in AB InBev (BUD) in Q2 2026: 805 shares worth $66.3K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings.

612 funds tracked by Wall St. Rank hold BUD as of Q2 2026.

Cary Street Partners held 805 shares of AB InBev worth $66.3K as of Q2 2026.
AB InBev was a new Cary Street Partners position in Q2 2026.
AB InBev made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #1028 holding.
612 funds tracked by Wall St. Rank held AB InBev as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.